Synthesis and evaluation of benzothiophene derivatives as ligands for imaging β-amyloid plaques in Alzheimer's disease
Synthesis and evaluation of benzothiophene derivatives as ligands for imaging β-amyloid plaques in Alzheimer's disease
复制标题
DOI:
10.1016/j.nucmedbio.2006.06.006
复制
发表时间:
2006-08-01
影响因子:
3.1
通讯作者:
Lee, Myung Chul
中科院分区:
文献类型:
--
作者:
Chang, Young Soo;Jeong, Jae Min;Lee, Myung Chul
The imaging of the distribution of beta-amyloid (A beta), plaques in the brain is becoming an important diagnostic modality in Alzheimer's disease (AD). Here, we synthesized novel benzothiophene derivatives and labeled them with F-18 for the potential diagnostic imaging of AD patients using positron emission tomography. The K-i values of benzothiophene derivatives were evaluated by competitive binding assay using 2-(3'-[I-125]iodo-4'-N-methylaminophenyl)benzothiazole as a radioligand and A beta(1-40) or A beta(1-42) aggregates as receptors. All synthesized benzothiophene derivatives showed high binding affinities (K-i=0.28-6.50 nM) to both A beta(1-40) and A beta(1-42) aggregates. Binding affinities were increased by 0-alkylation or N-alkylation of 2-(4'-hydroxyphenyl)benzothiophene or 2-(4'-aminophenyl)benzothiophene. Biodistribution studies of 2-(4'-O-(2-[F-18]fluoroethyl)hydroxyphenyl)benzothiophene ([F-18]2d) and 2-(4'-O-(3'-[F-18]fluoropropyl)hydroxyphenyl)benzothiophene ([F-18]2d) in normal mice were performed after intravenous injection through the tail vein. In biodistribution data, [F-18]2c and [F-18]2d showed high initial brain uptakes at 2 min (5.2 +/- 0.4% and 3.3 +/- 0.2% ID/g, respectively), and brain activities washed out to 2.0 +/- 0.2% and 0.5 +/- 0.1% ID/g at 4 h, respectively. In conclusion, benzothiophene derivatives showed excellent binding affinities for A beta aggregates and high initial brain uptakes in normal mice. (c) 2006 Elsevier Inc. All rights reserved.